Aveanna Healthcare (NASDAQ:AVAH) Upgraded at Raymond James Financial

Raymond James Financial upgraded shares of Aveanna Healthcare (NASDAQ:AVAH) from an outperform rating to a strong-buy rating in a research report report published on Friday morning, MarketBeat Ratings reports. They currently have $13.00 price target on the stock.

A number of other research firms have also recently weighed in on AVAH. Weiss Ratings reiterated a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Monday, December 29th. Zacks Research lowered shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 3rd. Royal Bank Of Canada lifted their price target on shares of Aveanna Healthcare from $10.00 to $11.00 and gave the stock a “sector perform” rating in a report on Thursday, January 15th. UBS Group increased their price objective on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “neutral” rating in a report on Thursday, January 15th. Finally, William Blair started coverage on Aveanna Healthcare in a research report on Monday, December 8th. They issued an “outperform” rating for the company. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $10.81.

Aveanna Healthcare Price Performance

AVAH opened at $6.52 on Friday. The firm has a market cap of $1.42 billion, a P/E ratio of 6.39 and a beta of 2.07. The firm has a 50-day moving average of $7.84 and a 200 day moving average of $8.49. The company has a debt-to-equity ratio of 6.62, a quick ratio of 1.32 and a current ratio of 1.32. Aveanna Healthcare has a fifty-two week low of $3.73 and a fifty-two week high of $10.32.

Insider Transactions at Aveanna Healthcare

In other news, insider Edwin C. Reisz sold 60,769 shares of the business’s stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $438,144.49. Following the sale, the insider owned 1,447,057 shares of the company’s stock, valued at $10,433,280.97. The trade was a 4.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Patrick A. Cunningham sold 18,436 shares of the company’s stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $132,923.56. Following the sale, the insider owned 337,755 shares in the company, valued at $2,435,213.55. The trade was a 5.18% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 998,595 shares of company stock worth $7,567,770 over the last quarter. Corporate insiders own 7.00% of the company’s stock.

Institutional Investors Weigh In On Aveanna Healthcare

Several institutional investors have recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after acquiring an additional 2,400 shares during the period. Quantbot Technologies LP bought a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at $43,000. Oxford Asset Management LLP bought a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at $64,000. Dynamic Technology Lab Private Ltd purchased a new stake in Aveanna Healthcare during the 2nd quarter worth about $68,000. Finally, PharVision Advisers LLC purchased a new stake in Aveanna Healthcare during the 2nd quarter worth about $78,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Key Stories Impacting Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Q4 results beat consensus — revenue grew strongly year‑over‑year and the company topped EPS and revenue estimates, providing fundamental support for the stock. Press Release
• Positive Sentiment: Raymond James upgraded AVAH to “strong-buy” and set a $13 price target, which is a bullish catalyst and likely helping intraday buying interest. Finviz item
• Neutral Sentiment: BMO trimmed its price target from $11 to $10 but maintained an “outperform” rating — a modest pullback in upside but not a negative rating change. Benzinga
• Neutral Sentiment: Aveanna issued 2026 guidance and a growth outlook; the details are being parsed by investors and helped explain the mixed market reaction (earnings beat vs. cautious forward commentary). TipRanks
• Neutral Sentiment: Reported short‑interest entries show anomalous “0 shares”/NaN data for March (data likely erroneous), so short‑interest signals are not meaningful right now.
• Negative Sentiment: Truist lowered its price target to $9 and moved to a “hold” rating, reducing analyst support and putting downside pressure on the stock. Benzinga
• Negative Sentiment: Market headlines flagged that Aveanna’s revenue outlook/trend in guidance trailed some consensus expectations, which prompted a pullback in some coverage and weighed on sentiment. MSN

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.